Mississippi House Bill HB379

Mississippi 2026 Regular Session

• Introduced: 1/9/26
• Refer: 1/9/26
• Failed: 2/3/26

Caption

Screening and approval program for retail sale of products containing certain substances; establish.

Impact

The legislation mandates that the State Health Officer, or a designated representative, is responsible for approving or denying the sale of these products based on available evidence. This administrative structure is intended to streamline the regulatory process and enhance oversight, although it raises questions about the efficacy of such a program in truly curbing substance abuse. The approval process is designed to provide a method for manufacturers or distributors to appeal decisions if their products are denied, which adds an important element of accountability to the process.

Summary

House Bill 379 establishes a program within the State Department of Health aimed at overseeing the over-the-counter availability and retail sale of certain products containing substances that could potentially be abused recreationally. The bill seeks to define such substances and create a robust screening and approval process designed to mitigate the risks associated with these items, which include, but are not limited to substances like bath salts, kratom, and tianeptine. The bill reflects a growing concern over the accessibility of substances that can lead to health issues due to their potential for misuse.

Contention

One notable point of contention within the bill is its provision that allows municipalities and counties to maintain their regulations regarding the substances in question. This creates a dual-layered regulatory environment in which local laws can coexist with state legislation. As such, there may be discrepancies between statewide policies and those at the local level. Some stakeholders and community leaders may argue that local control is essential for addressing specific community needs that general state regulations might overlook.